Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis
Links shared publicly online about this topic.
- 400total visits
Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis
The National Institute for Health and Clinical Excellence (NICE) has today (30 March 2011) opened a consultation on draft guidance which does not recommend abatacept (Orencia, Bristol-Myers Squibb
View full resource at medicalnewstoday.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Healthy Living, Orencia, Bristol-Myers Squibb
Most Recently Shared on March 31, 2011 at 2:56 am By:
Draft NICE Guidance Does Not Recommend Abatacept For Second-line Use In Rheumatoid Arthritis: The National Insti... http://bit.ly/dZu1fo
Advertisement
